Are you healthy and looking to help advance medical science?

You may be eligible to participate in a acute biphenotypic leukemia clinical study, and could be compensated for your time.

Are you healthy and looking to help advance medical science? You may be eligible to participate in a acute biphenotypic leukemia clinical study, and could be compensated for your time.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Acute Biphenotypic Leukemia Clinical Trial
NCT03779854 | Phase 2 | Interventional

Are you healthy and looking to help advance medical science?

You may be eligible to participate in a acute biphenotypic leukemia clinical study, and could be compensated for your time.

Are you healthy and looking to help advance medical science? You may be eligible to participate in a acute biphenotypic leukemia clinical study, and could be compensated for your time.

Recruiting

Male & Female

6 Months -
22 Years

This study is looking to recruit 68 Participants

This phase II trial studies how well naive T-cell depletion works in preventing chronic graft-versus-host disease in children and young adults with blood cancers undergoing donor stem cell transplant. Sometimes the transplanted white blood cells from a donor attack the body's normal tissues (called graft versus host disease). Removing a particular type of T cell (naive T cells) from the donor cells before the transplant may stop this from happening.